Zoltan Kalo

Zoltan Kalo

Mexikói Street 65/A
Budapest, BU 1142, Hungary

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 180 publications

From general-purpose models to purpose-built artificial intelligence systems for health economic modeling.

From general-purpose models to purpose-built artificial intelligence systems for health economic modeling.

Journal: Expert review of pharmacoeconomics & outcomes research

Published: August 17, 2026

Principles of selecting cost-effectiveness thresholds in price-taker countries.

Principles of selecting cost-effectiveness thresholds in price-taker countries.

Journal: Expert review of pharmacoeconomics & outcomes research

Published: August 07, 2026

Policy approach to optimize multiple myeloma treatment sequencing practices.

Policy approach to optimize multiple myeloma treatment sequencing practices.

Journal: Expert review of hematology

Published: February 18, 2026

Innovating HTA: a call for capacity building and standardization.

Innovating HTA: a call for capacity building and standardization.

Journal: International journal of technology assessment in health care

Published: January 28, 2026

Unlocking the benefits of allopurinol: the role of timely initiation and adherence in cardiovascular and renal outcomes in hyperuricemia.

Unlocking the benefits of allopurinol: the role of timely initiation and adherence in cardiovascular and renal outcomes in hyperuricemia.

Journal: European journal of internal medicine

Published: January 22, 2026

Methodological guidelines for Health Technology Assessment in Oman.

Methodological guidelines for Health Technology Assessment in Oman.

Journal: Journal of pharmaceutical policy and practice

Published: December 12, 2025

Establishing multiple cost-effectiveness thresholds in Oman: a stakeholder-driven approach.

Establishing multiple cost-effectiveness thresholds in Oman: a stakeholder-driven approach.

Journal: Health economics review

Published: November 27, 2025

Policy barriers to drug repurposing in Europe: different stakeholder perspectives identified during survey-based shortlisting of key challenges.

Policy barriers to drug repurposing in Europe: different stakeholder perspectives identified during survey-based shortlisting of key challenges.

Journal: Health policy OPEN

Published: November 24, 2025

Collective international action to increase access to costly drugs: pooled procurement and equity based tiered pricing.

Collective international action to increase access to costly drugs: pooled procurement and equity based tiered pricing.

Journal: BMJ (Clinical research ed.)

Published: November 11, 2025

Policies to promote affordability and access across the life cycle of costly new drugs.

Policies to promote affordability and access across the life cycle of costly new drugs.

Journal: BMJ (Clinical research ed.)

Published: November 11, 2025

Social framework to judge the importance of breast cancer.

Social framework to judge the importance of breast cancer.

Journal: Journal of cancer policy

Published: August 01, 2025

Optimization of pharmaceutical research and development by early-phase assessment of investigational medicinal products.

Optimization of pharmaceutical research and development by early-phase assessment of investigational medicinal products.

Journal: British journal of clinical pharmacology

Published: June 26, 2025

Showing 1-12 of 180

Last Updated: 09/26/2026